Effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Quality of Life in Chronic Cancer Pain
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Quality of Life, Chronic Cancer Pain
In brief
This study aims to objectively evaluate the effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation (PC-TEAS) on improving the quality of life in patients with chronic cancer pain, thereby providing evidence-based medical support for its efficacy and offering practical basis for patients to achieve home-based auxiliary treatment based on their own needs. Furthermore, by observing and comparing changes in indicators such as pain-related scores, analgesic consumption, emotional scores, spontaneous bowel movements, and adverse events, this research will comprehensively assess the advantages of PC-TEAS in the management of chronic cancer pain and explore other potential benefits of this intervention for patients.
Key facts
- Study ID
- NCT07308951
- Run by
- The Third Affiliated hospital of Zhejiang Chinese Medical University
- People needed
- 290
- Starts
- 2025-09-10
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-12-30
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age between 18 and 80 years, regardless of gender;
- Diagnosis of primary or metastatic malignant tumor confirmed by histopathology and/or cytology, consistent with the American Cancer Society criteria for malignancy;
- Presence of cancer-related pain, defined as an average Numeric Rating Scale (NRS) score ≥ 2 over the preceding week or current regular use of opioid analgesics;
- Life expectancy ≥ 3 months;
- Eastern Cooperative Oncology Group Performance Status (ECOG-PS) score ≤ 2, stable vital signs, clear consciousness, intact pain perception, unimpaired communication, ability to cooperate with study procedures and complete assessments;
- Provision of signed informed consent by the patient or their legal guardian after comprehensive explanation of the study;
You may not qualify if…
- Pain not attributable to cancer;
- Severe cardiopulmonary dysfunction or respiratory depression;
- Implantation of cardiac pacemaker or metallic implants at stimulation sites;
- Local skin lesions or conditions unsuitable for TEAS at the acupoint sites;
- Severe psychiatric disorders or significant cognitive impairment;
- Concurrent participation in other clinical trials that may interfere with the outcome evaluation of this study;
- Previous history of transcutaneous electrical acupoint stimulation (TEAS) or transcutaneous electrical nerve stimulation (TENS);
Where it is running
- The Third Affiliated Hospital of Zhejiang Chinese Medicinal University — Zhejiang, Hangzhou, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.